ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1412	National Cancer Institute	Html	en	Lung Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.	skin cancer 0.349544 cancer treatment 0.344722 cancer prevention trials 0.366779 lung cancer screening 0.424963 lung cancer prevention 0.444623 prevention clinical trials 0.358195 protective factors 0.365293 following PDQ summaries 0.35677 PDQ cancer information 0.428189 lung cancer 0.930545 clinical trials 0.420475 secondhand smoke 0.364049 important risk factor 0.350351 cancer information summary 0.398033 small cell lung 0.428578 left lung 0.393411 breast cancer prevention 0.35675 cancer patients 0.344267 cancer risk factor 0.388012 low-dose spiral ct 0.356728 NCI PDQ cancer 0.3773 radiation therapy 0.36772 new cases 0.35557 CT scans 0.355102	cancer risk factors 0.383293 cancer protective factor 0.369464 smokers 0.342644 Atomic bomb radiation 0.359839 Cancer Information Service 0.361682 spiral CT scans 0.353441 common cancer 0.34956 smoking 0.374366 Prevention Editorial Board 0.360434 lower their risk 0.346462 National Cancer Institute 0.402346 new lung cancers 0.398324 smoking low tar 0.343862 Cancer Care page 0.356844 right lung 0.388076 non-small cell lung 0.429832 people 0.358421 PDQ summary 0.34571 cancer -causing agents 0.363798 cancer clinical trials 0.36639 cell lung cancer 0.479294 risk factors 0.409463 cancer information summaries 0.364825 comprehensive cancer information 0.364576	CLICK HERE
1520	National Cancer Institute	Html	null	Esophageal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of esophageal cancer.			CLICK HERE
1527	National Cancer Institute	Html	en	Ovarian Germ Cell Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian germ cell tumors.	cancer treatment 0.301769 cancer spreads 0.255348 malignant tumor cells 0.277558 body 0.299082 germ cell tumor 0.800721 chemotherapy 0.280839 PDQ cancer information 0.300273 Recurrent ovarian germ 0.277404 clinical trial search 0.309632 clinical trials 0.590656 cancer information summary 0.281932 clinical trial 0.395991 ovarian cancer 0.264692 patients 0.271425 total abdominal hysterectomy 0.337207 primary treatment 0.256866 treatment clinical trial 0.254498 NCI PDQ cancer 0.256529 Treatment Option Overview 0.259623 surgical procedure 0.271995 radiation therapy 0.310569 Treatment Editorial Board 0.252931 General information 0.260406 Serum tumor marker 0.253975	general cancer information 0.252204 treatment 0.470981 ovarian germ cell 0.990461 abdomen 0.27139 Peritoneal Cancer Treatment 0.272441 NCI-supported cancer 0.272026 cancer cells 0.336912 Cancer Information Service 0.252497 treatment clinical trials 0.274003 National Cancer Institute 0.311767 Primary Peritoneal Cancer 0.275614 tumor cells 0.338991 new treatment 0.324139 diagnose ovarian germ 0.30268 combination chemotherapy 0.271369 primary tumor 0.253062 metastatic tumor 0.262931 germ cell tumors 0.577174 common ovarian germ 0.287657 cancer clinical trials 0.319376 stage 0.300535 fallopian tubes 0.264303 cancer 0.662842 information 0.326655	CLICK HERE
1691	National Cancer Institute	Html	en	Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®)–Health Professional Version	Calcium, green tea, lycopene, pomegranate, selenium, soy and vitamin E have been studied for prostate cancer prevention or treatment. Read about laboratory and human studies on various prostate supplements in this expert-reviewed summary.	atypical small acinar 0.591788 dietary lycopene 0.5816 local-stage prostate cancer 0.605358 prostate cancer cell 0.611618 prostate cancer survivors 0.597981 total prostate cancer 0.586726 occult prostate cancer 0.591218 lycopene serum concentration 0.581941 lycopene intake 0.604495 prostate cancer cells. 0.594787 serum lycopene 0.591044 hormone-refractory prostate cancer 0.585389 metastatic prostate cancer 0.596215 cancer prostate cells 0.587339 prostate cancer incidence 0.586787 prostate cancer cells 0.74273 prostate cancer risk 0.675977 prostate cancer patients 0.695715 serum lycopene concentrations 0.582255 prostate cancer aggressiveness 0.585035 prostate cancer progressi 0.584763 lycopene 0.683385 end-of-study prostate lycopene 0.623399 Prostate Cancer Prevention 0.597202 serum psa levels 0.589012	human prostate cancer 0.61272 plasma lycopene levels 0.594142 study 0.645275 androgen-independent prostate cancer 0.585034 prostate cancer development 0.59941 nonmetastatic prostate cancer 0.584711 -resistant prostate cancer 0.587482 high-grade prostate cancer 0.596056 Prostate CAncer Therapy 0.605352 prostate cancer mortality 0.5969 prostate cancer biomarkers 0.590502 prostate cancer cases 0.586568 prostate lycopene concentration 0.627986 green tea 0.644093 prostate cancer patients. 0.585445 lycopene blood levels 0.586499 prostate cancer 0.954937 prostate cancer. 0.620441 aggressive prostate cancer 0.587452 prostate cancer risk. 0.60813 prostate cancer progression 0.591862 prostate lycopene concentrations 0.629097 lycopene levels 0.595352 small acinar proliferation 0.592927	CLICK HERE
1698	National Cancer Institute	Html	en	Topics in Integrative, Alternative, and Complementary Therapies (PDQ®)–Patient Version	Expert-reviewed information summary that contains information on integrative, complementary, and/or alternative therapies for people with cancer.	treatment 0.496567 cancer treatment 0.492995 cancer prevention 0.491725 Complementary Therapies Editorial 0.451339 Cancer Information Specialist 0.463468 cancer cells 0.485902 section 0.463945 Cancer Information Service 0.487907 Herbs/Dietary Supplements section 0.454711 Cancer Complementary 0.464741 breast cancer section 0.455211 CAM therapies 0.453618 specific PDQ summary 0.507776 dietary supplements 0.518422 National Cancer Institute 0.533776 studies 0.454937 clinical trials 0.547318 cancer information summary 0.522295 alternative medicine 0.513784 PDQ documents 0.462433 alternative cancer therapies 0.45948 clinical trial 0.455001 prostate cancer cells 0.455068 CAM cancer research 0.449455	PDQ health 0.555354 PDQ summaries 0.468855 cancer patients 0.523763 PDQ database 0.46397 PDQ Topics 0.462207 fight cancer 0.449901 breast cancer 0.455561 prostate cancer patients 0.471774 NCI’s PDQ 0.468435 PDQ summary 0.513781 professional summary 0.498282 body fight cancer 0.448775 NCI PDQ cancer 0.502954 cancer information database 0.46436 prostate cancer 0.542459 complementary therapies 0.470524 alternative therapies 0.455648 hot flashes 0.501425 cancer information summaries 0.489288 cancer 0.694704 information 0.593851 PDQ Integrative 0.464074 PDQ patient summary 0.974252	CLICK HERE
1906	National Cancer Institute	Html	es	Tratamiento de la leucemia linfocítica crónica (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfocítica crónica.	origen judío ruso 0.422021 siguientes procedimientos 0.424569 células madre 0.989491 estadio iv 0.439551 siguientes aspectos 0.415966 proteína llamada bcl2 0.417559 leucemia linfoblástica aguda 0.524325 hueso compacto 0.45509 neoplasias mieloides 0.413049 rayos x 0.41087 Chronic Lymphocytic Leukemia 0.453986 estadios i 0.422864 enlace drugs approved 0.452281 célula madre mieloide 0.477075 células mieloides 0.465027 células t 0.445647 células anormales.ampliar aspiración 0.467907 National Cancer Institute 0.4112 sexo masculino 0.412514 Instituto Nacional 0.418791	LLC mejora 0.413093 célula madre linfoide 0.435741 PDQ Tratamiento 0.432911 exploración tep 0.412807 siguientes problemas 0.415002 presente sección 0.408632 leucemia mielógena 0.445228 explorador tep 0.413444 tirosina cinasa 0.45926 Physician Data Query 0.439508 estadio iii 0.439039 linfocitos t 0.431485 laboratorio piezas 0.414056 Antecedentes familiares 0.410684 leucemia mieloide aguda 0.50943 célula madre 0.588281 células sanguíneas maduras 0.551856 gen igvh 0.469992 siguientes sumarios 0.426268 siguientes pruebas 0.415779	CLICK HERE
1928	National Cancer Institute	Html	es	Tratamiento de los tumores de células germinativas del ovario (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de células germinativas del ovario.	células cancerosas destruyéndolas 0.567328 siguientes procedimientos 0.5945 estadio iv 0.763261 ovarios causa efectos 0.720865 siguientes tipos 0.44103 rayos x 0.435181 estadio ic 0.701359 estadio ib 0.706097 estadio ia 0.703099 enlace drugs approved 0.444726 Fallopian Tube 0.427273 células reproductoras 0.578706 área anormal.ampliar examen 0.456393 peritoneal primario 0.43365 estadio iva 0.49879 National Cancer Institute 0.427112 Instituto Nacional 0.496637 estadio iiia 0.688436 PDQ Tratamiento 0.459552	ligera presión 0.438027 estadio iiic 0.681996 ganglios linfáticos detrás 0.589451 estadio iia 0.703376 células madres 0.693148 cortará pequeños trozos 0.469591 presente sección 0.423353 estadio iic 0.591971 Physician Data Query 0.497349 or primary peritoneal 0.449903 estadio iii 0.989912 Nuevas opciones 0.42339 siguientes situaciones 0.508188 histerectomía abdominal 0.832509 siguientes pruebas 0.525524 siguientes sumarios 0.47228 corto tiempo 0.424715 siguientes estadios 0.515179	CLICK HERE
3568	National Cancer Institute	Html	en	An Overview of NCI’s National Clinical Trials Network	Information about the National Clinical Trial Network’s structure and a synopsis of how NCTN improves the speed and efficiency of cancer clinical trials.	clinical trials experts 0.464501 future clinical trials 0.469163 University Comprehensive Cancer 0.556492 new clinical trials 0.515991 University Cancer Center 0.54987 lung cancer 0.503721 Colorado Cancer Center 0.501413 National Clinical Trials 0.541018 Siteman Cancer Center 0.555425 clinical trials 0.992586 Laboratory Cancer Center 0.490529 Cancer Center 0.943642 University Medical Center 0.534585 Stephenson Cancer Center 0.498802 Michigan Comprehensive Cancer 0.464216 Collaborating Clinical Trials 0.493315 NCI Community Cancer 0.50292 precision medicine 0.594538 Canadian Network Group 0.472202 multi-site clinical trials 0.481274 NCTN group 0.467958 precision medicine trials 0.572352 Cancer Research Center 0.514033 Case Comprehensive Cancer 0.469578 NCTN trials 0.551195	network groups 0.486781 Lineberger Comprehensive Cancer 0.520793 NCI clinical trials 0.553596 Anderson Cancer Center 0.500046 Clinical Trials Quality 0.474372 Clinical Trials Network 0.579967 Farber/Harvard Cancer Center 0.50471 Carbone Cancer Center 0.498624 Davis Comprehensive Cancer 0.464747 Simmons Cancer Center 0.49746 Winship Cancer Institute 0.520221 new national clinical 0.508498 Cooperative Group program 0.540619 Yale Cancer Center 0.49495 Ohio State University 0.480826 Comprehensive Cancer Center 0.860218 Kimmel Comprehensive Cancer 0.464896 Chicago Comprehensive Cancer 0.464567 previous clinical trials 0.494398 Cancer Institute 0.668695 cancer clinical trials 0.605684 cell lung cancer 0.474785 Cotton Cancer Center 0.50297 Ingram Cancer Center 0.497253	CLICK HERE
16653	National Cancer Institute	Html	en	IOTF Mentors: Track 3 and Track 4	While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 3 and 4.	regulatory review 0.859055 Radiological Health 0.80074 review process 0.801152 project 0.796601 radiation therapy devices 0.823079 office 0.805677 Biologics Evaluation 0.882543 research 0.878646 therapy medical products 0.786754 medical products 0.814349 division 0.805276 cell-based medical products 0.805668 Biotechnology Products 0.814932 research program 0.805393 cell culture cells 0.78633 gene therapy products 0.878795 stem cells 0.79941 development 0.787013 cancer risk assessment 0.792173 gene therapy 0.961714 nucleic acid 0.824416 investigational new drug 0.905511 drug applications 0.79082 new drug products 0.789184	neoplastic cell substrates 0.79142 radiation therapy 0.854476 cancer chemotherapy 0.787392 radiation therapy treatments 0.789697 FDA 0.8111 Drug Evaluation 0.832004 Drug Administration 0.845645 cell 0.852835 therapeutic proteins 0.875837 cell therapy 0.796306 regulatory review scientist 0.807408 iotf fellow 0.867768 Principal Investigator 0.803321 Center 0.786741 early cancer detection 0.787952 Cancer Health Claims 0.787284 gene therapies 0.879766 cells 0.826854 immune cell activation 0.789452 fellow 0.909256 gene therapy applications 0.81743 cancer risk 0.812916 new medical products 0.802617 cancer 0.939352	CLICK HERE
16864	National Cancer Institute	Html	es	Selected Vegetables y Sun's Soup (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de Selected Vegetables y Sun's Soup como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Frozen SV 0.301838 Sun’s Soup 0.622837 Selected Vegetables 0.989854 specific dietary supplement 0.365272 multi-institutional prospective study 0.301068 Wang LH 0.31046 Sun Farm 0.310084 Instituto Nacional 0.303518 peso corporal promedio 0.301106 IV non-small 0.334303 Estados Unidos 0.309279 tratamiento simultáneoc puntaje 0.301389 Sun’s Soup“ 0.302908 allium cepa l 0.300921 patients taking 0.307016 non-small cell lung 0.365258 Lentinus edodes 0.303332 Sun Farm Corporation 0.305751 frijol mungo 0.301357 alimentario selected vegetables 0.303781 patients with 0.301382 investigación clínica 0.301025 glycine max l 0.300858 Yeh HC 0.310747 herbal treatment 0.309558	crataegus oxyacantha l 0.300911 Trademark Office 0.305198 puntaje promedio 0.304049 allium bakeri regel 0.300852 estadio iv 0.311573 Sun's Soup 0.425399 Pilot study 0.310803 glycyrrhiza glabra l 0.300901 cáncer número 0.301303 frijoles mungo 0.303086 Nutr Cancer 0.335867 US Patent 0.318672 Ryznar V 0.306737 Farm Vegetable Soup 0.306615 Ostadal O 0.306698 accessed april 0.311866 porcentaje promedio 0.301352 allium fistulosum l 0.300943 Glycine max 0.301356 Freeze-dried SV 0.300819 sesamum indicum l 0.300901 pacientes sí 0.303642 phaseolus radiatus l 0.305677 República Checa 0.301327	CLICK HERE